Buserelin (Suprefact)
434
relevant articles (58 outcomes,
91 trials/studies)
found for this Bio-Agent
Description:
A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications.
Also Known As:
Suprefact; Aventis Brand of Buserelin; Aventis Brand of Buserelin Acetate; Bigonist; Buserelin Acetate; HOE-766; Hoechst Brand of Buserelin Acetate; Intervet Brand of Buserelin Acetate; Profact; Receptal; Suprecur; Tiloryth; Acetate, Buserelin; Buserelin Aventis Brand; HOE 766; HOE766; Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-
Relationship Network
Bio-Agent Context: Research Results